Daily Stock Analysis, MMSI, Merit Medical Systems Inc, priceseries

Merit Medical Systems, Inc. designs, develops, manufactures and markets single-use medical products for interventional and diagnostic procedures. The company operates through two operating segments: Cardiovascular and Endoscopy. The Cardiovascular segment consists of cardiology and radiology devices which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases and includes the embolotherapeutic products acquired through the acquisition of BioSphere Medical, Inc. The Endoscopy segment includes gastroenterology and pulmonology medical devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Merit Medical Systems was founded by Fred P. Lampropoulos, Kent W. Stanger and William Padilla in July 1987 and is headquartered in South Jordan, UT.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets medical products for interventional and diagnostic procedures worldwide. The company's Cardiovascular segment offers cardiology and radiology devices for diagnosing and treating coronary arterial, peripheral vascular, and other non-vascular diseases; and embolotherapeutic products. It also provides vascular access products; guide wires, inflation devices, and diagnostic catheters for use in angiography procedures; therapeutic infusion systems and safety products; drainage catheters and drainage access products, support catheters, vascular retrieval devices, and dialysis access products; and embosphere microspheres and delivery systems, and microcatheters. In addition, this segment offers needles, scalpels, hemostasis devices, arm boards, and sheath introducers for cardiology procedures; fluid management and tubing, manifolds, syringes, transducers, and diagnostic catheters; hemostasis valves, MAP Merit Angioplasty Packs, and angioplasty accessories; cardiac rhythm management and electrophysiology devices; and various devices, accessories, kits, and procedure trays. The company's Endoscopy segment provides gastroenterology and pulmonology devices for expanding esophageal, tracheobronchial, and biliary strictures caused by malignant tumors. It also offers non-vascular, esophageal, and biliary stents; esophageal balloon dilators; kits and accessories for the endoscopy and bronchoscopy markets; coating services for medical tubes and wires under OEM brands; and microelectromechanical systems sensor components. The company serves hospitals and clinic-based cardiologists, radiologists, neurologists, nephrologists, vascular and orthopaedic surgeons, interventional gastroenterologists and pulmonologists, physiatrists, general surgeons, thoracic surgeons, oncologists, electrophysiologists, technicians, and nurses. The company was founded in 1987 and is headquartered in South Jordan, Utah.